# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA4361668 | Binding | Inhibition of human recombinant GST-tagged ALK5 expressed in Sf9 insect cells at 10 uM using casein as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay relative to control | Homo sapiens | 16 | ALA4359846 | cell-based format | Scientific Literature | |
2. | ALA4361669 | Binding | Inhibition of human recombinant untagged p38alpha expressed in Escherichia coli at 10 uM using ATF2 as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay relative to control | Homo sapiens | 22 | ALA4359846 | assay format | Scientific Literature | |
3. | ALA4361670 | Binding | Inhibition of human recombinant GST-tagged ALK5 expressed in Sf9 insect cells using casein as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay | Homo sapiens | 16 | ALA4359846 | cell-based format | Scientific Literature | |
4. | ALA4361671 | Binding | Inhibition of human recombinant untagged p38alpha expressed in Escherichia coli using ATF2 as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay | Homo sapiens | 16 | ALA4359846 | assay format | Scientific Literature | |
5. | ALA4361672 | Binding | Selectivity index, ratio of IC50 for human recombinant untagged p38alpha expressed in Escherichia coli to IC50 for human recombinant GST-tagged ALK5 expressed in Sf9 insect cells | Homo sapiens | 16 | ALA4359846 | cell-based format | Scientific Literature | |
6. | ALA4361673 | ADME | Cytotoxicity against human LX2 cells assessed as reduction in cell viability at 4 to 100 uM incubated for 3 hrs by MTT assay | Homo sapiens | 2 | ALA4359846 | cell-based format | Scientific Literature | |
7. | ALA4361674 | Binding | Inhibition of ALK5 in human LX2 cells assessed as reduction in TGFbeta-induced collagen 1 production pretreated for 1 hr followed by TGFbeta addition and measured after 12 hrs by DAPI staining based immunocytochemistry analysis by confocal laser scanning microscopic method | Homo sapiens | 2 | ALA4359846 | cell-based format | Scientific Literature | |
8. | ALA4361675 | Binding | Inhibition of ALK5 in human LX2 cells assessed as reduction in TGFbeta-induced alphaSMA production pretreated for 1 hr followed by TGFbeta addition and measured after 12 hrs by DAPI staining based immunocytochemistry analysis by confocal laser scanning microscopic method | Homo sapiens | 2 | ALA4359846 | cell-based format | Scientific Literature | |
9. | ALA4361678 | Binding | Inhibition of ALK5 in human LX2 cells assessed as reduction in TGFbeta-induced collagen 1 protein expression at 1.25 to 5 uM pretreated for 1 hr followed by TGFbeta addition and measured after 12 hrs by Western blot analysis | Homo sapiens | 2 | ALA4359846 | cell-based format | Scientific Literature | |
10. | ALA4361679 | Binding | Inhibition of ALK5 in human LX2 cells assessed as reduction in TGFbeta-induced alphaSMA protein expression at 1.25 to 5 uM pretreated for 1 hr followed by TGFbeta addition and measured after 12 hrs by Western blot analysis | Homo sapiens | 2 | ALA4359846 | cell-based format | Scientific Literature | |
11. | ALA4361680 | Binding | Inhibition of ALK5 in human LX2 cells assessed as reduction in TGFbeta-induced ACTA2 mRNA expression at 1.25 to 5 uM pretreated for 1 hr followed by TGFbeta addition and measured after 12 hrs by RT-PCR analysis | Homo sapiens | 2 | ALA4359846 | cell-based format | Scientific Literature | |
12. | ALA4361681 | Binding | Inhibition of ALK5 in human LX2 cells assessed as reduction in TGFbeta-induced COL1A1 mRNA expression at 1.25 to 5 uM pretreated for 1 hr followed by TGFbeta addition and measured after 12 hrs by RT-PCR analysis | Homo sapiens | 2 | ALA4359846 | cell-based format | Scientific Literature |